Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review | ||
| dc.conicet.organizacion | Universidade Estadual de Campinas | |
| dc.conicet.organizacion | Universidade Federal do Rio de Janeiro | |
| dc.conicet.organizacion | Universidade Estadual de Campinas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial | |
| dc.conicet.organizacion | Federal Institute of Science and Technology of Rio de Janeiro | |
| dc.conicet.organizacion | Universidade Federal de Sao Paulo | |
| dc.conicet.organizacion | Universidade Estadual de Campinas | |
| dc.contributor.author | Xavier Santos, Douglas | |
| dc.contributor.author | Padilha, Marina | |
| dc.contributor.author | Fabiano, Giovanna Alexandre | |
| dc.contributor.author | Vinderola, Celso Gabriel | |
| dc.contributor.author | Gomes Cruz, Adriano | |
| dc.contributor.author | Sivieri, Katia | |
| dc.contributor.author | Costa Antunes, Adriane Elisabete | |
| dc.date.issued | 2022-02 | |
| dc.description.abstract | Background: Coronavirus disease-19 (COVID-19) is an infectious disease transmitted by the virus responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), which exhibit several clinical manifestations including gastrointestinal symptoms. Scope and approach: This review aimed to provide insights and perspectives for the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention/treatment and/or modulation of the microbiota in COVID-19 patients. Eighty-four studies published in the Scopus database from the onset of the pandemic until December 2021 were assessed and submitted to a bibliometric analysis adapted from VOSviewer software. Key findings and conclusions: Through bibliometric analysis, it might be suggested that the modulation of the gut/lung microbiome is promising as an adjuvant for the prevention/treatment of COVID-19 patients, due to immunomodulation properties related to probiotics and prebiotics. So far, few clinical studies involving the application of probiotics in COVID-19 patients have been completed, but reduction in the duration of the disease and the severity of symptoms as fatigue, olfactory dysfunction and breathlessness, nausea and vomiting and other gastrointestinal symptoms were some of the main findings. However, probiotics are not recommended to immunocompromised patients in corticosteroid therapy. The future perspectives point to the modulation of the intestinal microbiota by probiotics, prebiotics, synbiotics, and postbiotics represent a promising adjuvant approach for improving the health of patients with COVID-19. | es |
| dc.description.fil | Fil: Xavier Santos, Douglas. Universidade Estadual de Campinas; Brasil | |
| dc.description.fil | Fil: Padilha, Marina. Universidade Federal do Rio de Janeiro; Brasil | |
| dc.description.fil | Fil: Fabiano, Giovanna Alexandre. Universidade Estadual de Campinas; Brasil | |
| dc.description.fil | Fil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina | |
| dc.description.fil | Fil: Gomes Cruz, Adriano. Federal Institute of Science and Technology of Rio de Janeiro; Argentina | |
| dc.description.fil | Fil: Sivieri, Katia. Universidade Federal de Sao Paulo; Brasil | |
| dc.description.fil | Fil: Costa Antunes, Adriane Elisabete. Universidade Estadual de Campinas; Brasil | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Xavier Santos, Douglas; Padilha, Marina; Fabiano, Giovanna Alexandre; Vinderola, Celso Gabriel; Gomes Cruz, Adriano; et al.; Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review; Elsevier Science London; Trends In Food Science & Technology (regular Ed.); 120; 2-2022; 174-192 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0924-2244 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/216382 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.pagination | 174-192 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Trends In Food Science & Technology (regular Ed.) | es |
| dc.journal.volume | 120 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier Science London | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.tifs.2021.12.033 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | DIET | es |
| dc.subject | FUNCTIONAL FOODS | es |
| dc.subject | GUT-LUNG AXIS | es |
| dc.subject | IMMUNOMODULATION | es |
| dc.subject | MICROBIOME | es |
| dc.subject | PANDEMIC | es |
| dc.subject | COVID-19 | es |
| dc.subject.classification | Otras Ingenierías y Tecnologías | es |
| dc.subject.classification | Otras Ingenierías y Tecnologías | es |
| dc.subject.classification | INGENIERÍAS Y TECNOLOGÍAS | es |
| dc.title | Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.9693e8ee-49bb-4bae-afdc-23615f6a4c2b_F.pdf
- Tamaño:
- 5.87 MB
- Formato:
- Adobe Portable Document Format
- Descripción: